Weight Loss Management in Endometrial Cancer Survivors

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2030

Conditions
Endometrial Cancer SurvivorsWeight ManagementEarly Stage Endometrial Cancer
Interventions
BEHAVIORAL

Weight loss with pharmacotherapy

Patients will meet with a weight management specialist and discuss their options for weight loss including medications (GLP-1 agonist, naltrexone/bupropion, orlistat, or phentermine/topiramate) or bariatric surgery.

BEHAVIORAL

Weight loss without pharmacotherapy

Participants not on medications will have their weight recorded at subsequent cancer surveillance or other routine medical visits

Trial Locations (1)

66160

RECRUITING

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER